PHARMACEUTICAL PRODUCT FOR PREVENTION AND TREATMENT OF PROGRESSING MYOPIDITY

摘要

1. A pharmaceutical preparation for the prevention and treatment of progressive myopia, which is an aqueous solution for instillations, or an eye gel, or an ophthalmic film containing an effective amount of an amine with functional groups in the form of a salt, or as part of a transition metal complex compound, or mixtures thereof. 2. The preparation according to claim 1, characterized in that the concentration of a salt or complex compound of an amine-based transition metal with functional groups in solution is 0.15-7.0 wt.%. 3. The preparation according to claim 1, characterized in that distilled water or an isotonic solution or a mixture thereof is used as the aqueous medium for the solution. The preparation according to claim 3, characterized in that the physiological or balanced physiological solution of BBS and / or aqueous solutions of nonionic compounds, such as glycerin, or sorbitol, or beckons, or propylene glycol, or dextrose, are selected as the isotonic solution. The drug according to claim 1, characterized in that the aqueous solution further comprises a gelling agent. The preparation according to claim 5, characterized in that the gelling agent used is hyaluronic acid, chondroitin sulfate, or polyvinyl alcohol, or methyl cellulose, or hydroxyethyl cellulose, or hydroxypropyl cellulose, or hydroxypropyl guar, or polyethylene glycol-polypropylene glycol-polyethylene glycol cellulose-copolymer, polyethylene glycol cellulose a salt of a crosslinked polyacrylic acid and its copolymers with C10-30 alkyl acrylates, or a mixture thereof. 7. The preparation according to claims 5 and 6, characterized in that the content of the gelling agent in the aqueous solution is 0.1-25.0 wt.%. 8. A drug